Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features
Top Cited Papers
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 57 (3) , 846-862
- https://doi.org/10.1046/j.1523-1755.2000.057003846.x
Abstract
No abstract availableKeywords
This publication has 146 references indexed in Scilit:
- Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodiesJournal of Internal Medicine, 1998
- Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1Journal of Hepatology, 1997
- Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodiesQJM: An International Journal of Medicine, 1996
- Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiencyQJM: An International Journal of Medicine, 1996
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosisQJM: An International Journal of Medicine, 1996
- Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpuraClinical and Experimental Immunology, 1994
- Wegener granulomatosis in children and adolescents: Clinical presentation and outcomeThe Journal of Pediatrics, 1993
- Stage-adapted treatment of Wegener's granulomatosisJournal of Molecular Medicine, 1989
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988